Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ľuboš Janotka"'
Autor:
Lukáš Ďurina, Anna Ďurinová, František Trejtnar, Ľuboš Janotka, Lucia Messingerová, Jana Doháňošová, Ján Moncol, Róbert Fischer
Publikováno v:
Beilstein Journal of Organic Chemistry, Vol 17, Iss 1, Pp 2781-2786 (2021)
A new highly diastereoselective synthesis of the polyhydroxylated pyrrolidine alkaloid (±)-codonopsinol B and its N-nor-methyl analogue, starting from achiral materials, is presented. The strategy relies on the trans-stereoselective epoxidation of 2
Externí odkaz:
https://doaj.org/article/ed8bdf273d414f67a2f2de7e570a8772
Autor:
Anna Ďurinová, Ján Moncol, Ľuboš Janotka, Lucia Messingerová, Jana Doháňošová, Lukáš Ďurina, František Trejtnar, Róbert Fischer
Publikováno v:
Beilstein Journal of Organic Chemistry
Beilstein Journal of Organic Chemistry, Vol 17, Iss 1, Pp 2781-2786 (2021)
Beilstein Journal of Organic Chemistry, Vol 17, Iss 1, Pp 2781-2786 (2021)
A new highly diastereoselective synthesis of the polyhydroxylated pyrrolidine alkaloid (±)-codonopsinol B and its N-nor-methyl analogue, starting from achiral materials, is presented. The strategy relies on the trans-stereoselective epoxidation of 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c50d1d5916807d4d1d03d3c214fd5dd
http://europepmc.org/articles/PMC8630432
http://europepmc.org/articles/PMC8630432
Autor:
Ľuboš Janotka, Kristína Šimoničová, Michal Sahulčík, Lucia Messingerová, Radka Štadániová, Ján Moncol, Jana Doháňošová, Róbert Fischer
Publikováno v:
European Journal of Organic Chemistry. 2020:4775-4786
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0385a5fa512e4be2aad94e1fe6a84666
https://doi.org/10.1002/ejoc.202000737
https://doi.org/10.1002/ejoc.202000737
Autor:
Kristína Šimoničová, Ľuboš Janotka, Helena Kavcová, Zdena Sulová, Albert Breier, Lucia Messingerova
Publikováno v:
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy. 61
Resistance to the hypomethylating agents (HMAs) 5-azacytidine (AZA) and 5-aza-2'-deoxycytidine (DAC) represents a major obstacle in the treatment of elderly patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) which are not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34d3d4f50c0c6c12d27c2947e0a1831a
https://pubmed.ncbi.nlm.nih.gov/35227933
https://pubmed.ncbi.nlm.nih.gov/35227933
Autor:
Albert Breier, Zdena Sulova, Lucia Messingerová, Katarína Elefantová, Helena Kavcova, Kristína Šimoničová, Ľuboš Janotka
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 4
International Journal of Molecular Sciences, Vol 22, Iss 2076, p 2076 (2021)
Volume 22
Issue 4
International Journal of Molecular Sciences, Vol 22, Iss 2076, p 2076 (2021)
We established the following two variants of the MOLM-13 human acute myeloid leukemia (AML) cell line: (i) MOLM-13/DAC cells are resistant to 5-aza-2′-deoxycytidine (DAC), and (ii) MOLM-13/AZA are resistant to 5-azacytidine (AZA). Both cell variant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46ca09cbba34a62c84b8f3658619f628